Treatment options for erectile dysfunction

被引:44
作者
Brant, William O.
Bella, Anthony J.
Lue, Tom F.
机构
[1] Univ Colorado, Sch Med, Vail, CO 81658 USA
[2] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.ecl.2007.02.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A wide variety of medications, devices, and surgical interventions are available to patients who have ED. These range from first-line oral agents to second-line therapy with injections or vacuum devices to third-line options, such as penile prosthesis implantation. In this article, we cover available treatments for erectile dysfunction, ranging from first-line to third-line therapies.
引用
收藏
页码:465 / +
页数:16
相关论文
共 84 条
[1]   A vacuum device for penile elongation: fact or fiction? [J].
Aghamir, MK ;
Hosseini, R ;
Alizadeh, F .
BJU INTERNATIONAL, 2006, 97 (04) :777-778
[2]  
Aköz T, 1999, PLAST RECONSTR SURG, V103, P1975
[3]   Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction [J].
Bechara, A ;
Casabe, A ;
Cheliz, G ;
Romano, S ;
Rey, H ;
Fredotovich, N .
JOURNAL OF UROLOGY, 1997, 157 (06) :2132-2134
[4]   AN IMPROVED VASOACTIVE DRUG-COMBINATION FOR A PHARMACOLOGICAL ERECTION PROGRAM [J].
BENNETT, AH ;
CARPENTER, AJ ;
BARADA, JH .
JOURNAL OF UROLOGY, 1991, 146 (06) :1564-1565
[5]   Surgical treatment of penile veno-occlusive dysfunction: Is it justified? [J].
Berardinucci, D ;
Morales, A ;
Heaton, JPW ;
Fenemore, J ;
Bloom, S .
UROLOGY, 1996, 47 (01) :88-92
[6]   USE OF GLYCOSYLATED HEMOGLOBIN TO IDENTIFY DIABETICS AT HIGH-RISK FOR PENILE PERIPROSTHETIC INFECTIONS [J].
BISHOP, JR ;
MOUL, JW ;
SIHELNIK, SA ;
PEPPAS, DS ;
GORMLEY, TS ;
MCLEOD, DG .
JOURNAL OF UROLOGY, 1992, 147 (02) :386-388
[7]  
Boolell M, 1996, Int J Impot Res, V8, P47
[8]   Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses [J].
Brock, GB ;
McMahon, CG ;
Chen, KK ;
Costigan, T ;
Shen, W ;
Watkins, V ;
Anglin, G ;
Whitaker, S .
JOURNAL OF UROLOGY, 2002, 168 (04) :1332-1336
[9]   Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism [J].
Burnett, AL ;
Bivalacqua, TJ ;
Champion, HC ;
Musicki, B .
UROLOGY, 2006, 67 (05) :1043-1048
[10]   Risk factors for penile prosthetic infection [J].
M. Çakan ;
F. Demirel ;
O. Karabacak ;
F. Yalçınkaya ;
U. Altuğ .
International Urology and Nephrology, 2003, 35 (2) :209-213